Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Dissecting the genomic complexity underlying medulloblastoma.

Jones DT, Jäger N, Kool M, Zichner T, Hutter B, Sultan M, Cho YJ, Pugh TJ, Hovestadt V, Stütz AM, Rausch T, Warnatz HJ, Ryzhova M, Bender S, Sturm D, Pleier S, Cin H, Pfaff E, Sieber L, Wittmann A, Remke M, Witt H, Hutter S, Tzaridis T, Weischenfeldt J, Raeder B, Avci M, Amstislavskiy V, Zapatka M, Weber UD, Wang Q, Lasitschka B, Bartholomae CC, Schmidt M, von Kalle C, Ast V, Lawerenz C, Eils J, Kabbe R, Benes V, van Sluis P, Koster J, Volckmann R, Shih D, Betts MJ, Russell RB, Coco S, Tonini GP, Schüller U, Hans V, Graf N, Kim YJ, Monoranu C, Roggendorf W, Unterberg A, Herold-Mende C, Milde T, Kulozik AE, von Deimling A, Witt O, Maass E, Rössler J, Ebinger M, Schuhmann MU, Frühwald MC, Hasselblatt M, Jabado N, Rutkowski S, von Bueren AO, Williamson D, Clifford SC, McCabe MG, Collins VP, Wolf S, Wiemann S, Lehrach H, Brors B, Scheurlen W, Felsberg J, Reifenberger G, Northcott PA, Taylor MD, Meyerson M, Pomeroy SL, Yaspo ML, Korbel JO, Korshunov A, Eils R, Pfister SM, Lichter P.

Nature. 2012 Aug 2;488(7409):100-5. doi: 10.1038/nature11284.

2.

Medulloblastomics: the end of the beginning.

Northcott PA, Jones DT, Kool M, Robinson GW, Gilbertson RJ, Cho YJ, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM.

Nat Rev Cancer. 2012 Dec;12(12):818-34. doi: 10.1038/nrc3410. Review.

3.

Medulloblastoma molecular dissection: the way toward targeted therapy.

Remke M, Ramaswamy V, Taylor MD.

Curr Opin Oncol. 2013 Nov;25(6):674-81. doi: 10.1097/CCO.0000000000000008. Review.

PMID:
24076581
4.

Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.

Gupta T, Shirsat N, Jalali R.

Curr Pediatr Rev. 2015;11(2):106-19. Review.

PMID:
26133181
5.

Signaling pathway and molecular subgroups of medulloblastoma.

Li KK, Lau KM, Ng HK.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1211-22. Print 2013. Review. Erratum in: Int J Clin Exp Pathol. 2015;8(9):11945.

6.

Molecular Classification of Medulloblastoma.

Kijima N, Kanemura Y.

Neurol Med Chir (Tokyo). 2016 Nov 15;56(11):687-697. Epub 2016 May 26. Review.

7.

Mouse models of medulloblastoma.

Wu X, Northcott PA, Croul S, Taylor MD.

Chin J Cancer. 2011 Jul;30(7):442-9. doi: 10.5732/cjc.011.10040. Review.

8.

Medulloblastoma stem cells.

Fan X, Eberhart CG.

J Clin Oncol. 2008 Jun 10;26(17):2821-7. doi: 10.1200/JCO.2007.15.2264. Review.

9.

The role of chromatin remodeling in medulloblastoma.

Jones DT, Northcott PA, Kool M, Pfister SM.

Brain Pathol. 2013 Mar;23(2):193-9. doi: 10.1111/bpa.12019. Review.

PMID:
23432644
10.

[Progress of molecular pathology in pediatric brain tumor].

WANG YJ, PIAO YS, LU DH.

Zhonghua Bing Li Xue Za Zhi. 2011 Mar;40(3):206-8. Review. Chinese. No abstract available.

PMID:
21575401
11.

Medulloblastomas in adults: prognostic factors and lessons from paediatrics.

Fellay CN, Frappaz D, Sunyach MP, Franceschi E, Brandes AA, Stupp R.

Curr Opin Neurol. 2011 Dec;24(6):626-32. doi: 10.1097/WCO.0b013e32834cd4b1. Review.

PMID:
22027544
12.

Medulloblastoma: From Myth to Molecular.

Ramaswamy V, Taylor MD.

J Clin Oncol. 2017 Jul 20;35(21):2355-2363. doi: 10.1200/JCO.2017.72.7842. Epub 2017 Jun 22. Review.

PMID:
28640708
13.

A mouse model for medulloblastoma and basal cell nevus syndrome.

Corcoran RB, Scott MP.

J Neurooncol. 2001 Jul;53(3):307-18. Review.

PMID:
11718263
14.

p53 and Meduloblastoma.

Ramaswamy V, Nör C, Taylor MD.

Cold Spring Harb Perspect Med. 2015 Dec 18;6(2):a026278. doi: 10.1101/cshperspect.a026278. Review. Erratum in: Cold Spring Harb Perspect Med. 2016;6(4). pii: a029579. doi: 10.1101/cshperspect.a029579.

PMID:
26684332
15.

SHH desmoplastic/nodular medulloblastoma and Gorlin syndrome in the setting of Down syndrome: case report, molecular profiling, and review of the literature.

Mangum R, Varga E, Boué DR, Capper D, Benesch M, Leonard J, Osorio DS, Pierson CR, Zumberge N, Sahm F, Schrimpf D, Pfister SM, Finlay JL.

Childs Nerv Syst. 2016 Dec;32(12):2439-2446. Epub 2016 Jul 21. Review.

PMID:
27444290
16.

RNA binding protein-mediated post-transcriptional gene regulation in medulloblastoma.

Bish R, Vogel C.

Mol Cells. 2014 May;37(5):357-64. doi: 10.14348/molcells.2014.0008. Epub 2014 Mar 6. Review.

17.

Review: personalized mice: modelling the molecular heterogeneity of medulloblastoma.

Markant SL, Wechsler-Reya RJ.

Neuropathol Appl Neurobiol. 2012 Jun;38(3):228-40. doi: 10.1111/j.1365-2990.2011.01235.x. Review.

PMID:
22070547
18.

Genetic and molecular alterations across medulloblastoma subgroups.

Skowron P, Ramaswamy V, Taylor MD.

J Mol Med (Berl). 2015 Oct;93(10):1075-84. doi: 10.1007/s00109-015-1333-8. Epub 2015 Sep 9. Review.

19.

Medulloblastoma biology in the post-genomic era.

Archer TC, Pomeroy SL.

Future Oncol. 2012 Dec;8(12):1597-604. doi: 10.2217/fon.12.151. Review.

20.

Evasion of cell senescence in SHH medulloblastoma.

Tamayo-Orrego L, Swikert SM, Charron F.

Cell Cycle. 2016 Aug 17;15(16):2102-2107. Epub 2016 May 26. Review.

Supplemental Content

Support Center